Browse > Article

Effects of Recombinant Human Erythropoietin Treatment in Male Cynomolgus (Macaca fascicularis) Monkeys (II): Gene Expression Profiling in Spleen  

Yoon, Seok-Joo (Korea Institute of Toxicology, KRICT)
Hwang, Ji-Yoon (Korea Institute of Toxicology, KRICT)
Lim, Jung-Sun (Korea Institute of Toxicology, KRICT)
Jeong, Sun-Young (Korea Institute of Toxicology, KRICT)
Kim, Yong-Bum (Korea Institute of Toxicology, KRICT)
Kim, Dal-Hyun (R&D Center of Pharmaceuticals, CJ Corp.)
Kwon, Myung-Sang (School of Veterinary Medicine, Kangwon National University)
Han, Sang-Seop (Korea Institute of Toxicology, KRICT)
Kim, Choong-Yong (Korea Institute of Toxicology, KRICT)
Publication Information
Toxicological Research / v.21, no.3, 2005 , pp. 209-218 More about this Journal
Abstract
We investigated effects of recombinant human erythropoietin (rHuEPO) on profiles of mRNA transcripts in 6 male cynomolgus (M. fascicularis) monkey's spleen for 4 weeks. Six monkeys, composed of control and treatment group (Control : M1, M2, M3: Treatment : M4, M5, M6) were intravenously administered 3 times per week without or with a dose of rHuEPO 2730 IU/0.1 ml/kg. After 4 weeks rHuEPO treatment, spleen was removed for RNA isolation. Splenic gene expression was assessed using Affymetrix U133A 2.0 arrays containing 18,400 transcripts and variants, including 14,500 well-characterized human genes. Gene expression pattern was very different between individuals even in same treatment. In rHuEPO treated groups showed number of genes were up- or down-regulated (M4: 79: M5: 48; M6: 73 genes). Six genes (epidermal growth factor receptor, calgranulin A, estrogen receptor binding site associated antigen, matrix metalloproteinase 19, zinc finger and BTB domain containing 16, progestin and adipoQ receptor) were commonly expressed in rHuEPO treated group. The different individual response could be major considering factor in monkey experiment. Further study is needed to clarify the different individual response to rHuEPO in molecular level. This study will be valuable in the fundamental understanding and validation of molecular toxicology for bio-generic drugs including rHuEPO in cynomolgus monkey.
Keywords
rHuEPO; Cynomolgus monkey; Gene expression; Spleen; Microarray;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Eschbach, J.W., Abdulhadi, M.H. and Browne, J.K. (1989) Recombinant human erythropoietin in anemic patients with end-stage renal diseases. Results of a phase III multicenter clinical trial. Ann. Intem. Med., 111, 992-1000   DOI
2 Furuno, T., Komatsu, H., Noguchi, N., Noguchi, G, Suzuki, S., Kataoka, S., Saito, K., Tatsumi, T. and Usami, M. (1990) Thirteen-week intravenous toxicity study of EPOCH in Rhesus monkeys (Macaca mulatta). J. Clin. Ther. Med., 6, 271-289
3 Gebbia, V., Palmeri, S., Valenza, R, Rausam, L. and Citarella, P. (1991) The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinuminduced anemia in Golden Syrian hamsters. In Vivo, 5, 149-152
4 Koury, S.T., Bondurant, M.C. and Koury, M.J. (1988) Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood, 71, 524-527
5 McDonald, T.P., Cottrell, M.B., Steward, S.A., Clift, RE., Swearingen, C.J. and Jackson, C.W. (1992) Comparison of platelet production in two strains of mice with different model megakaryocyte DNA ploidies after exposure to hypoxia. Exp. Hematol., 20, 51-58
6 Vaziri, N.D., Zhou, X.J. and Liao, S.Y. (1994) Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am. Physiol. Soc., 266, F360-366   DOI
7 Karpatkin, S., Garg, S.K .and Freedman, M.L. (1974) Role of iron as a regulator of thrombopoiesis. Am. J. Med., 57, 521-525   DOI   ScienceOn
8 Lin, F.K., Suggs, S., Kin, C.H., Browne, J.K., Smalling, R, Egrie, J.C., Cjen, K.K., Fox, G.M., Martin, F., Stabinsky, Z., Badrawi, S.M., Lai, PH. and Goldwasser, E. (1985) Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 82, 7580-7584   DOI
9 Jacobs, K., Shoemaker, C., Rudersdorf, R., Neil, S.D., Kaufman, R.J., Mufson, A., Seehra, J., Jones, S.S., Hewick, R., Fretch, E.F., Kawakita, M., Shimizu, T. and Miyake, T. (1985) Isolation and characterization of genomics and eDNA clones of human erythropoietin. Nature, 313, 806-810   DOI   ScienceOn
10 Shriver, Z., Raguram, S. and Sasisekharan, R .(2004) Glycomics: A pathway to a class of new and improved therapeutics. Nature Reviews Drug Discovery, 3, 863-873   DOI   ScienceOn
11 McDonald, T.P., Cottrell, M.B. and Clift, R.E. (1978) Effects of short-term hypoxia on platelet counts of mice. Blood, 51, 165-170
12 Jackson, C.W., Simone, J.V. and Edwards, C.C. (1974) The relationship of anemia and thrombocytosis. J. Lab. Clin. Med., 84, 357-368
13 KHIDI (2004) 유전자재조합 의약품 연구동향. Trends in Health Industry & Technology, Fall 30-38
14 Eschbach, J.W. and Adamson, J.W. (1989) Guidelines for recombinant human erythropoietin therapy. Am. J. Kidney Dis., 14, 1, 2-8   DOI
15 Beguin, Y, Loo, M. and R'Zik, S. (1994) Effect od recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. Eur. J. Haematol., 53, 265-270   DOI   ScienceOn
16 Fisher, J.W. (1993) Recent advances in erythropoietin research. Prog. Drug Res., 41, 293-311